Dulaglutide 1.5 mg Significantly Improves Glycemic Control and Lowers LDL-Cholesterol and Body Weight in Romanian Patients with Type 2 Diabetes.

RPEP-101862025Bobu, Amelian Madalin; Turliuc, Serban; Cucu, Andrei Ionut; Onofriescu, Alina; Dascalu, Cristina Gena; Costea, Claudia Florida; Patrascanu, Emilia; Morosan, Anca Petruta; Haisan, Anca; Filip, Carmen Nicoleta; Covali, Roxana; Buzduga, Catalin Mihai; Botnariu, Gina; Enache, Irina Iuliana Costache

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Dulaglutide 1.5 mg Significantly Improves Glycemic Control and Lowers LDL-Cholesterol and Body Weight in Romanian Patients with Type 2 Diabetes.

Journal of clinical medicine, 14(10)

View on PubMed ↗Publisher’s paper ↗

Citation

Bobu, Amelian Madalin; Turliuc, Serban; Cucu, Andrei Ionut; Onofriescu, Alina; Dascalu, Cristina Gena; Costea, Claudia Florida; Patrascanu, Emilia; Morosan, Anca Petruta; Haisan, Anca; Filip, Carmen Nicoleta; Covali, Roxana; Buzduga, Catalin Mihai; Botnariu, Gina; Enache, Irina Iuliana Costache. (2025). Dulaglutide 1.5 mg Significantly Improves Glycemic Control and Lowers LDL-Cholesterol and Body Weight in Romanian Patients with Type 2 Diabetes.. Journal of clinical medicine, 14(10). https://doi.org/10.3390/jcm14103536